BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 25666543)

  • 21. Review of adjunctive dexmedetomidine in the management of severe acute alcohol withdrawal syndrome.
    Wong A; Smithburger PL; Kane-Gill SL
    Am J Drug Alcohol Abuse; 2015; 41(5):382-91. PubMed ID: 26337198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome.
    Lee JA; Duby JJ; Cocanour CS
    Clin Toxicol (Phila); 2019 Jul; 57(7):624-627. PubMed ID: 30729859
    [No Abstract]   [Full Text] [Related]  

  • 23. Alcohol Withdrawal Syndrome in Neurocritical Care Unit: Assessment and Treatment Challenges.
    Farrokh S; Roels C; Owusu KA; Nelson SE; Cook AM
    Neurocrit Care; 2021 Apr; 34(2):593-607. PubMed ID: 32794143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition and treatment of the alcohol withdrawal syndrome.
    Leroy JB
    Prim Care; 1979 Sep; 6(3):529-39. PubMed ID: 392576
    [No Abstract]   [Full Text] [Related]  

  • 25. [Assessment and Treatment of Alcohol Withdrawal Syndrome].
    Choi HY; Seo JS; Lee SK
    Korean J Gastroenterol; 2020 Aug; 76(2):71-77. PubMed ID: 32839369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eliminating the benzos: A benzodiazepine-sparing approach to preventing and treating alcohol withdrawal syndrome.
    McCullough MA; Miller PR; Martin T; Rebo KA; Stettler GR; Martin RS; Cantley M; Shilling EH; Hoth JJ; Nunn AM
    J Trauma Acute Care Surg; 2024 Mar; 96(3):394-399. PubMed ID: 37934662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of phenobarbital for prevention of alcohol withdrawal in trauma patients.
    Kip LM; Forni A; Dorfman JD; Li I
    J Trauma Acute Care Surg; 2023 Oct; 95(4):573-576. PubMed ID: 37418690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of alcohol withdrawal syndrome: new perspectives].
    Kádár BK; Pribék IK; Gajdics J; Szemelyácz J; Andó B; Lázár BA
    Orv Hetil; 2023 Sep; 164(38):1487-1496. PubMed ID: 37742220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
    Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ
    J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting.
    Elholm B; Larsen K; Hornnes N; Zierau F; Becker U
    Alcohol Alcohol; 2011; 46(3):318-23. PubMed ID: 21414950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study.
    Andaluz A; DeMoss D; Claassen C; Blair S; Hsu J; Bakre S; Khan M; Atem F; Rush AJ
    Am J Drug Alcohol Abuse; 2020; 46(1):49-57. PubMed ID: 31490712
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical management of the alcohol withdrawal syndrome.
    Day E; Daly C
    Addiction; 2022 Mar; 117(3):804-814. PubMed ID: 34288186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzodiazepine treatment for alcohol-dependent patients.
    Lejoyeux M; Solomon J; Adès J
    Alcohol Alcohol; 1998; 33(6):563-75. PubMed ID: 9872344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
    Woods AD; Giometti R; Weeks SM
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition, Assessment, and Pharmacotherapeutic Treatment of Alcohol Withdrawal Syndrome in the Intensive Care Unit.
    Foertsch MJ; Winter JB; Rhoades AG; Martin LT; Droege CA; Ernst NE
    Crit Care Nurs Q; 2019; 42(1):12-29. PubMed ID: 30507660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Dose Gabapentin for the Treatment of Severe Alcohol Withdrawal Syndrome: A Retrospective Cohort Analysis.
    Levine AR; Carrasquillo L; Mueller J; Nounou MI; Naut ER; Ibrahim D
    Pharmacotherapy; 2019 Sep; 39(9):881-888. PubMed ID: 31278761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostics and therapy of alcohol withdrawal syndrome: focus on delirium tremens and withdrawal seizure].
    Lutz UC; Batra A
    Psychiatr Prax; 2010 Sep; 37(6):271-8. PubMed ID: 20803410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal.
    Mayo-Smith MF
    JAMA; 1997 Jul; 278(2):144-51. PubMed ID: 9214531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcohol withdrawal: a nationwide survey of inpatient treatment practices.
    Saitz R; Friedman LS; Mayo-Smith MF
    J Gen Intern Med; 1995 Sep; 10(9):479-87. PubMed ID: 8523149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenobarbital and symptom-triggered lorazepam versus lorazepam alone for severe alcohol withdrawal in the intensive care unit.
    Nguyen TA; Lam SW
    Alcohol; 2020 Feb; 82():23-27. PubMed ID: 31326601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.